205 related articles for article (PubMed ID: 15888795)
1. Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
Iida H; Honda M; Kawai HF; Yamashita T; Shirota Y; Wang BC; Miao H; Kaneko S
Gut; 2005 Jun; 54(6):843-51. PubMed ID: 15888795
[TBL] [Abstract][Full Text] [Related]
2. alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis.
Kawai HF; Kaneko S; Honda M; Shirota Y; Kobayashi K
Hepatology; 2001 Mar; 33(3):676-91. PubMed ID: 11230749
[TBL] [Abstract][Full Text] [Related]
3. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
Saito S; Ojima H; Ichikawa H; Hirohashi S; Kondo T
Cancer Sci; 2008 Dec; 99(12):2402-9. PubMed ID: 19038010
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
5. EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma.
Cui XD; Lee MJ; Yu GR; Kim IH; Yu HC; Song EY; Kim DG
Int J Cancer; 2010 Feb; 126(4):940-9. PubMed ID: 19642143
[TBL] [Abstract][Full Text] [Related]
6. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway.
Zhang C; Zhang J; Wang J; Yan Y; Zhang C
J Cell Mol Med; 2020 Dec; 24(23):13804-13812. PubMed ID: 33090723
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
9. Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.
Kawaguchi K; Honda M; Yamashita T; Shirota Y; Kaneko S
Biochem Biophys Res Commun; 2005 Apr; 329(1):370-80. PubMed ID: 15721316
[TBL] [Abstract][Full Text] [Related]
10. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
11. Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells.
Zhu M; Li W; Guo J; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Li M
Oncotarget; 2016 Nov; 7(46):75749-75762. PubMed ID: 27716619
[TBL] [Abstract][Full Text] [Related]
12. Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma.
Wada H; Yamamoto H; Kim C; Uemura M; Akita H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
Int J Oncol; 2014 Sep; 45(3):1051-8. PubMed ID: 24969670
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
Zheng Y; Zhu M; Li M
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Liao W; Liu W; Liu X; Yuan Q; Ou Y; Qi Y; Huang W; Wang Y; Huang J
Oncotarget; 2015 Sep; 6(27):24132-47. PubMed ID: 26125229
[TBL] [Abstract][Full Text] [Related]
16. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Tang H; Tang XY; Liu M; Li X
Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897
[TBL] [Abstract][Full Text] [Related]
17. HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells.
Zhu M; Guo J; Li W; Xia H; Lu Y; Dong X; Chen Y; Xie X; Fu S; Li M
BMC Cancer; 2015 May; 15():362. PubMed ID: 25943101
[TBL] [Abstract][Full Text] [Related]
18. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.
Wang L; Huang J; Jiang M; Zheng X
Tumour Biol; 2010 Oct; 31(5):417-25. PubMed ID: 20532728
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
[TBL] [Abstract][Full Text] [Related]
20. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
